<p>Researchers from the Cleveland Clinic and IBM Research have developed a quantum machine learning framework to predict which tumor gene mutations generate immunogenic neoantigens—abnormal cell-surface proteins that trigger a therapeutic T-cell immune response. Published in Science Advances under t